Health utilities associated with hemoglobin levels and blood loss in postmenopausal women

The women's health initiative

Brooke S. Harrow, C. B. Eaton, M. B. Roberts, A. R. Assaf, Xuemei Luo, Zhao Chen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: The purpose of our study was to use health-related quality of clife data from the Women's Health Initiative to calculate health-related utility weights and examine differences in these health utility weights across different hemoglobin (Hgb) levels. These utility weights could then be used in future cost-effectiveness studies. Methods: Health utility weights were measured by the Short Form-6D (SF-6D), a health utility index derived from the Short Form Medical Outcomes questionnaire. Adjusted least square means were calculated for each level of Hgb at baseline and in longitudinal regression analysis the relationship between change in Hgb and change in the SF-6D was examined. Both baseline and longitudinal analyses were performed for all postmenopausal women and separately for those with self-reported heart failure, cancer, and osteoarthritis. Results: Womenwith Hgb in the anemic range had lower health utility weights than those with higher Hgb levels. Longitudinally, a loss of of 2 g/dl Hgb or more was associated with a statistically significant and clinically meaningfully decline in SF-6D in all participants and also in the group of participants with cancer and osteoarthritis, but not in those with heart failure. Conclusions: Lower levels of Hgb and a loss of Hgb are associated with a statistically significant and clinically meaningful decrement in health utility in all postmenopausal women we studied and also in those with chronic conditions.

Original languageEnglish (US)
Pages (from-to)555-563
Number of pages9
JournalValue in Health
Volume14
Issue number4
DOIs
StatePublished - Jun 2011

Fingerprint

Women's Health
Hemoglobins
Health
Weights and Measures
Osteoarthritis
Heart Failure
Heart Neoplasms
Least-Squares Analysis
Cost-Benefit Analysis
Regression Analysis

Keywords

  • Health utilities
  • hgb
  • Osteoarthritis
  • Postmenopausal

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Health utilities associated with hemoglobin levels and blood loss in postmenopausal women : The women's health initiative. / Harrow, Brooke S.; Eaton, C. B.; Roberts, M. B.; Assaf, A. R.; Luo, Xuemei; Chen, Zhao.

In: Value in Health, Vol. 14, No. 4, 06.2011, p. 555-563.

Research output: Contribution to journalArticle

Harrow, Brooke S. ; Eaton, C. B. ; Roberts, M. B. ; Assaf, A. R. ; Luo, Xuemei ; Chen, Zhao. / Health utilities associated with hemoglobin levels and blood loss in postmenopausal women : The women's health initiative. In: Value in Health. 2011 ; Vol. 14, No. 4. pp. 555-563.
@article{561344512b744e3dad4ac7b0c4d084b3,
title = "Health utilities associated with hemoglobin levels and blood loss in postmenopausal women: The women's health initiative",
abstract = "Objectives: The purpose of our study was to use health-related quality of clife data from the Women's Health Initiative to calculate health-related utility weights and examine differences in these health utility weights across different hemoglobin (Hgb) levels. These utility weights could then be used in future cost-effectiveness studies. Methods: Health utility weights were measured by the Short Form-6D (SF-6D), a health utility index derived from the Short Form Medical Outcomes questionnaire. Adjusted least square means were calculated for each level of Hgb at baseline and in longitudinal regression analysis the relationship between change in Hgb and change in the SF-6D was examined. Both baseline and longitudinal analyses were performed for all postmenopausal women and separately for those with self-reported heart failure, cancer, and osteoarthritis. Results: Womenwith Hgb in the anemic range had lower health utility weights than those with higher Hgb levels. Longitudinally, a loss of of 2 g/dl Hgb or more was associated with a statistically significant and clinically meaningfully decline in SF-6D in all participants and also in the group of participants with cancer and osteoarthritis, but not in those with heart failure. Conclusions: Lower levels of Hgb and a loss of Hgb are associated with a statistically significant and clinically meaningful decrement in health utility in all postmenopausal women we studied and also in those with chronic conditions.",
keywords = "Health utilities, hgb, Osteoarthritis, Postmenopausal",
author = "Harrow, {Brooke S.} and Eaton, {C. B.} and Roberts, {M. B.} and Assaf, {A. R.} and Xuemei Luo and Zhao Chen",
year = "2011",
month = "6",
doi = "10.1016/j.jval.2010.11.008",
language = "English (US)",
volume = "14",
pages = "555--563",
journal = "Value in Health",
issn = "1098-3015",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Health utilities associated with hemoglobin levels and blood loss in postmenopausal women

T2 - The women's health initiative

AU - Harrow, Brooke S.

AU - Eaton, C. B.

AU - Roberts, M. B.

AU - Assaf, A. R.

AU - Luo, Xuemei

AU - Chen, Zhao

PY - 2011/6

Y1 - 2011/6

N2 - Objectives: The purpose of our study was to use health-related quality of clife data from the Women's Health Initiative to calculate health-related utility weights and examine differences in these health utility weights across different hemoglobin (Hgb) levels. These utility weights could then be used in future cost-effectiveness studies. Methods: Health utility weights were measured by the Short Form-6D (SF-6D), a health utility index derived from the Short Form Medical Outcomes questionnaire. Adjusted least square means were calculated for each level of Hgb at baseline and in longitudinal regression analysis the relationship between change in Hgb and change in the SF-6D was examined. Both baseline and longitudinal analyses were performed for all postmenopausal women and separately for those with self-reported heart failure, cancer, and osteoarthritis. Results: Womenwith Hgb in the anemic range had lower health utility weights than those with higher Hgb levels. Longitudinally, a loss of of 2 g/dl Hgb or more was associated with a statistically significant and clinically meaningfully decline in SF-6D in all participants and also in the group of participants with cancer and osteoarthritis, but not in those with heart failure. Conclusions: Lower levels of Hgb and a loss of Hgb are associated with a statistically significant and clinically meaningful decrement in health utility in all postmenopausal women we studied and also in those with chronic conditions.

AB - Objectives: The purpose of our study was to use health-related quality of clife data from the Women's Health Initiative to calculate health-related utility weights and examine differences in these health utility weights across different hemoglobin (Hgb) levels. These utility weights could then be used in future cost-effectiveness studies. Methods: Health utility weights were measured by the Short Form-6D (SF-6D), a health utility index derived from the Short Form Medical Outcomes questionnaire. Adjusted least square means were calculated for each level of Hgb at baseline and in longitudinal regression analysis the relationship between change in Hgb and change in the SF-6D was examined. Both baseline and longitudinal analyses were performed for all postmenopausal women and separately for those with self-reported heart failure, cancer, and osteoarthritis. Results: Womenwith Hgb in the anemic range had lower health utility weights than those with higher Hgb levels. Longitudinally, a loss of of 2 g/dl Hgb or more was associated with a statistically significant and clinically meaningfully decline in SF-6D in all participants and also in the group of participants with cancer and osteoarthritis, but not in those with heart failure. Conclusions: Lower levels of Hgb and a loss of Hgb are associated with a statistically significant and clinically meaningful decrement in health utility in all postmenopausal women we studied and also in those with chronic conditions.

KW - Health utilities

KW - hgb

KW - Osteoarthritis

KW - Postmenopausal

UR - http://www.scopus.com/inward/record.url?scp=79959932580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959932580&partnerID=8YFLogxK

U2 - 10.1016/j.jval.2010.11.008

DO - 10.1016/j.jval.2010.11.008

M3 - Article

VL - 14

SP - 555

EP - 563

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 4

ER -